Didesmethylrocaglamide is primarily investigated for its potential in cancer research due to its ability to inhibit the proliferation of cancer cells. It works by targeting specific cellular pathways that are crucial for tumor growth, making it a promising candidate for developing anti-cancer therapies. Additionally, its role in modulating immune responses is being explored, which could lead to applications in treating autoimmune diseases or enhancing the efficacy of immunotherapies. Research is ongoing to further understand its mechanisms and optimize its therapeutic potential.